We recently demonstrated in EGFR overexpressing glioma cells that extracellular S1P produced by SK1 is involved in the increased invasiveness through the activation of the EGFRvIII-ERK-SK1-S1P pathway via the S1P1 receptor [31] (Figure 5). The gene discussed is EGFR; the disease is central nervous system cancer.